Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.

Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, Clerici M, Grossi E.

Immun Ageing. 2013 Jan 10;10(1):1. doi: 10.1186/1742-4933-10-1.

2.

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.

Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, D'hooghe MB, Dubois B, Raus J, Stinissen P.

J Neurosci Res. 2006 Jun;83(8):1432-46.

PMID:
16583400
3.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
5.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
6.

Vitamin D-mediated immune regulation in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

J Neurol Sci. 2011 Dec 15;311(1-2):23-31. doi: 10.1016/j.jns.2011.06.027. Epub 2011 Jul 2.

PMID:
21723567
7.

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A.

J Neuroimmunol. 2011 Mar;232(1-2):171-8. doi: 10.1016/j.jneuroim.2010.10.007. Epub 2010 Nov 26.

PMID:
21111488
8.

Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.

Alatab S, Maghbooli Z, Hossein-Nezhad A, Khosrofar M, Mokhtari F.

Minerva Med. 2011 Dec;102(6):461-8.

PMID:
22193377
9.

Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.

Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A.

Hum Mol Genet. 2011 Sep 15;20(18):3606-19. doi: 10.1093/hmg/ddr281. Epub 2011 Jun 15.

PMID:
21676896
10.

Memory and naive CD4+ lymphocytes in multiple sclerosis.

Porrini AM, Gambi D, Malatesta G.

J Neurol. 1992 Oct;239(8):437-40.

PMID:
1360022
11.

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.

Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK, Sancricca C, Mirabella M, Tonali PA, Batocchi AP.

J Neurosci Res. 2006 Oct;84(5):1027-36.

PMID:
16865709
12.

The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.

Okuda Y, Okuda M, Apatoff BR, Posnett DN.

J Neurol Sci. 2005 Aug 15;235(1-2):11-7.

PMID:
15972217
13.

The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.

Abo-Krysha N, Rashed L.

Mult Scler. 2008 Jun;14(5):602-8. doi: 10.1177/1352458507085550. Epub 2008 Apr 11.

PMID:
18408021
14.

Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.

Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE 3rd, Zivadinov R.

Neuroimage. 2007 Jul 1;36(3):746-54. Epub 2007 Apr 10.

PMID:
17498974
16.

HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.

Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, Abramsky O, Karussis D.

Arch Neurol. 1999 May;56(5):555-60.

PMID:
10328250
17.

Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients.

Zeman D, Adam P, Kalistová H, Sobek O, Kelbich P, Andel J, Andel M.

Acta Neurol Scand. 2000 Feb;101(2):89-94.

PMID:
10685854
18.

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

Giovannoni G, Lai M, Thorpe J, Kidd D, Chamoun V, Thompson AJ, Miller DH, Feldmann M, Thompson EJ.

Neurology. 1997 Jun;48(6):1557-65.

PMID:
9191766
19.

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.

Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R.

Arch Neurol. 2001 Jan;58(1):91-7.

PMID:
11176941
20.

[CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].

Bilińska M, Frydecka I, Kosmaczewska A, Ciszak L, Koszewicz M, Pokryszko-Dragan A.

Pol Merkur Lekarski. 2006 Jan;20(115):41-5. Polish.

PMID:
16617733

Supplemental Content

Support Center